Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells

被引:435
作者
Bettelli, E
Dastrange, M
Oukka, M
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA
[2] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Cambridge, MA 02139 USA
关键词
experimental autoimmune encephalomyelitis; transcription factors; CD4(+) T cells; interleukins;
D O I
10.1073/pnas.0501675102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Scurfy mice, which are deficient in a functional Foxp3, exhibit a severe lymphoproliferative disorder and display generalized overproduction of cytokines. Here, we show that, among the Foxp transcriptional factor family, which includes Foxp1, Foxp2, and Foxp3, only Foxp3 has the ability to inhibit IL-2, IL-4, and IFN-gamma production by primary T helper cells. We found that Foxp3 physically associates with the Rel family transcription factors, nuclear factor of activated T cells (NFAT) and NF-kappa B, and blocks their ability to induce the endogenous expression of their target genes, including key cytokine genes. More importantly, T cells derived from scurfy mice have a dramatic increase in nuclear factor of activated T cells (NFAT) and NF-kappa B transcriptional activity compared with the T cells derived from WT mice. Furthermore, complementation of Foxp3 in scurfy-derived T cells lowers the NFAT and NF-kappa B transcriptional activity to the physiological level. Finally, we show that myelin proteolipid protein-specific autoreactive T cells transduced with Foxp3 cannot mediate experimental autoimmune encephalomyelitis, providing further support that Foxp3 suppresses the effector function of autoreactive T cells. Foxp3 has already been associated with the generation of CD4(+)CD25(+) regulatory T cells; our data additionally demonstrate that Foxp3 suppresses the effector functions of T helper cells by directly inhibiting the activity of two key transcription factors, NFAT and NF-kappa B, which are essential for cytokine gene expression and T cell functions.
引用
收藏
页码:5138 / 5143
页数:6
相关论文
共 30 条
  • [1] Structural analysis of disease-causing mutations in the P-subfamily of forkhead transcription factors
    Banerjee-Basu, S
    Baxevanis, AD
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2004, 54 (04) : 639 - 647
  • [2] Banham AH, 2001, CANCER RES, V61, P8820
  • [3] Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome
    Barrans, SL
    Fenton, JAL
    Banham, A
    Owen, RG
    Jack, AS
    [J]. BLOOD, 2004, 104 (09) : 2933 - 2935
  • [4] The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
    Bennett, CL
    Christie, J
    Ramsdell, F
    Brunkow, ME
    Ferguson, PJ
    Whitesell, L
    Kelly, TE
    Saulsbury, FT
    Chance, PF
    Ochs, HD
    [J]. NATURE GENETICS, 2001, 27 (01) : 20 - 21
  • [5] Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis
    Bettelli, E
    Sullivan, B
    Szabo, SJ
    Sobel, RA
    Glimcher, H
    Kuchroo, VK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01) : 79 - 87
  • [6] BLAIR PJ, 1994, J IMMUNOL, V153, P3764
  • [7] Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
    Brunkow, ME
    Jeffery, EW
    Hjerrild, KA
    Paeper, B
    Clark, LB
    Yasayko, SA
    Wilkinson, JE
    Galas, D
    Ziegler, SF
    Ramsdell, F
    [J]. NATURE GENETICS, 2001, 27 (01) : 68 - 73
  • [8] Forkhead transcription factors: Key players in development and metabolism
    Carlsson, P
    Mahlapuu, M
    [J]. DEVELOPMENTAL BIOLOGY, 2002, 250 (01) : 1 - 23
  • [9] JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome
    Chatila, TA
    Blaeser, F
    Ho, N
    Lederman, HM
    Voulgaropoulos, C
    Helms, C
    Bowcock, AM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (12) : R75 - R81
  • [10] Clark LB, 1999, J IMMUNOL, V162, P2546